Stellar reports higher revenues but net losses remain steady

You are here: Home > Biotech > Current Article

Stellar reports higher revenues but net losses remain steady

By Staff Report / Tuesday, February 5th, 2019 / Comments Off on Stellar reports higher revenues but net losses remain steady

Stellar Biotechnologies reported an increase in revenue Feb. 5, but operating expenses also rose, keeping its net losses steady at around $1.41 million for its fiscal first quarter. In the earnings release, the Port Hueneme manufacturer of proteins used in experimental therapies said it had $50,000 in revenue for the quarter ended Dec. 31, up…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.